Beta Drugs Limited presented key highlights of its growth, including a strong EBITDA margin of 23.08% in the cosmeceutical market, acquisitions to reduce import dependence, and expansion into 46+ countries.
AI Assistant
Beta Drugs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.